Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare median overall survival of the test arm
(docetaxel and S-1) to the control arm (S-1 only) in subjects with advanced or recurrent
gastric cancer.